References
- 1. ELLULU M., ABED Y., RAHMAT A., RANNEH Y., ALI F., Epidemiology of obesity in developing countries: challenges and prevention, Global Epidemic Obesity, 2014.
- 2. WILBORN C., BECKHAM J., CAMPBELL B., HARVEY T., GALBREATH M., BOUNTY P.L. et al., Obesity: prevalence, theories, medical consequences, management, and research directions, J. Int. Soc. Sport. Nutr., 2005, 2(2):4–31.
- 3. RACHMI C.N., LI M., BAUR L.A., Overweight and obesity in Indonesia: prevalence and risk factors – a literature review, Public Health, 2017, 147:20–29.
- 4. ALBERTI K.G., ZIMMET P., SHAW J., Metabolic syndrome – a new world wide definition. A concencus state from the International Diabetes Federation, Diabet. Med., 2006, 23:469–480.
- 5. KARPE F., DICKMANN J.R., FRAYN K.N., Fatty acids, obesity, and insulin resistance: time for reevaluation, Diabetes, 2011; 60:2441–2447.
- 6. MCARDLE M.A., FINUCANE O.M., CONNAUGHTON R.M., MCMORROW A.M., ROCHE H.M., Mechanisms of obesity-induced inflamation and insulin resistance: insights into emerging role of nutritional strategies, Front. Endocrinol., 2013, 4:52.
- 7. TCHERNOF A., DESPRES J.P., Pathophysiology of Human Visceral Obesity: An Update, Physiol. Rev., 2013, 93:359–404.
- 8. PASQUALI R., VICENNATI V., GAMBINERI A., PAGOTTO U., Sex-Dependent Role of Glucocorticoids and Androgens in the Pathophysiology of Human Obesity, Int. J. Obes., 2008, 32(12):1764–1779.
- 9. BIANCHI V.E., Metabolic Syndrome, Obesity Paradox and Testosterone Level, Endocrinol. Metab. Synd., 2015, 4(2):1–16.
- 10. WANG C., JACKSON G., JONES T.H., MATSUMOTO A.M., NEHRA A., PERELMAN M.A. et al., Low Testosteron Associated with Obesity and the Metabolic Syndrome Contributes to Sexual Dysfunction and Cardiovascular Disease Risk in Men with Type 2 Diabetes, Diabetes Care, 2011, 34:1669–1673.
- 11. DI GUARDO F., CERANA M.C., D’URSO G., GENOVESE F., PALUMBO M., Male PCOS equivalent and nutritional restriction: are we stepping forward?, Med. Hypotheses, 2019, 126:1–3.
- 12. WU F., TAJAR A., PYE S.R., SILMAN A.J., FINN J.D. et al., Hypothalamic – Pituitary – Testicular Axis Disruptions in Older Men are Differentially Linked to Age and Modifiable Risk Factors: The European Male Aging Study, J. Clin. Endocrinol. Metab., 2008, 93:2737–2745.
- 13. TREMELLEN K., PEARCE K., Nutrition, Fertility, and Human Reproductive Function, CRC Press, Florida, 2015:58–261.
- 14. HOHL A., Testosterone from Basic to Clinical Aspects, Springer, Switzerland, 2017:149–159.
- 15. KELLY D.M., JONES T.H., Testosterone: A Metabolic Hormone in Health and Disease, J. Endocrinol., 2013, 217(3):R25–R45.
- 16. PITTELOUD N., MOOTHA V.K., DWYER A.A., HARDIN M., LEE H., ERIKSSON K.L. et al., Relationship Between Testosterone Levels, Insulin Sensitivity, and Mitochondrial Function in Men, Diabetes Care, 2005, 28:1636–1642.
- 17. CHEN X., LI X., HUANG H.Y., LI X., LIN J.F., Effect of Testosterone on Insulin Receptor Substrate-1 and Glucose Transporter 4 Expression in Cell Sensitive to Insulin, Zhonghua Yi Xue Za Zhi, 2006, 86:1474–1477.
- 18. CONTRERAS P.H., SERRANO F.G., SALGADO A.M., VIGIL P., Insulin Sensitivity and Testiscular Function in a Cohort of Adult Males Suspected of Being Insulin-Resistant, Front. Med., 2018, 5:190.
- 19. CHENG J., HAN B., LI Q., XIA F., ZHAI H., WANG N. et al., Testosterone: Relationship with Metabolic Disorders, in Men – An Observational Study from SPECT-China, Int. J. Endocrinol., 2017, Volume 2017, Article ID4547658.
- 20. LI C., FORD E.S., LI B., GILES W.H., LIU S., Association of Testosterone and Sex Hormone-Binding Globulin with Metabolic Syndrome and Insulin Resistance in Men, Diabetes Care, 2010, 33:1618–24.
- 21. HANCHANG W., SEMPRASERT N., LIMJINDAPORN T., YENCHITSOMANUS P.T., KOOPTIWUT S., Testosterone Protects Against Glucotoxicity – Induced Apoptosis of Pancreatic β Cells (INS-1) and Male Mouse Pancreatic Islets, Endocrinology, 2003, Vol. 154(11):4058–67.